• Nutex Health outlined an expansion strategy centered on micro-hospitals, with 28 facilities opened in 2026 and seven planned for 2026-2027.
• Full-year 2025 revenue rose 82.4% to $875.3 million; net income attributable to Nutex Health increased to $70.8 million.
• 2025 EBITDA increased 70.6% to $168.6 million; adjusted EBITDA jumped 152.6% to $259.6 million.
• For the three months ended June 30, 2026, net income attributable to Nutex Health was $65.8 million; diluted EPS was $9.38.
• Hospital Division visits rose 9.6% to 49,962; net cash from operating activities increased to $34.2 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutex Health Inc. published the original content used to generate this news brief on August 19, 2026, and is solely responsible for the information contained therein.